Skip to main contentSkip to navigation
Sirius Investors

OGI Stock: Organigram Global Inc. Stock Price, Analysis & Insights

Get live OGI stock price $1.06, comprehensive Organigram Global Inc. stock analysis, charts, news, and expert forecast. Real-time OGI stock data and investment insights.

1.06
1.85%Today
OGIOrganigram Global Inc. • NASDAQ Global Select • Healthcare
Market Cap
149.22M
Volume
232.95K
52W High
2.24
52W Low
1.04

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical canna...

Company Information

CEO
James H. Yamanaka
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1093

Contact Information

Address
35 English Drive
Country
CA

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Higher growth potential with elevated volatility (Beta: 1.43)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Organigram Global Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Organigram Global Inc.
  • Investors should consider how Organigram Global Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

149.22M

P/E Ratio (TTM)

-7.07

Beta

1.43

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.